Rhee v. Sante Ventures

CourtDistrict Court, S.D. New York
DecidedMay 8, 2023
Docket1:21-cv-04283
StatusUnknown

This text of Rhee v. Sante Ventures (Rhee v. Sante Ventures) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rhee v. Sante Ventures, (S.D.N.Y. 2023).

Opinion

USDC SDNY DOCUMENT SOUTHERN DISTRICT OF NEW YORK DOC #: nnn nnn nnn nnn nn nnn nnn ens nnn nnn ann ncncnnnnnn KK DATE FILED: __ 5/8/2023 YOUNGJOO RHEE, : Plaintiff, : : 21-cv-4283 (LJL) -V- : : OPINION AND ORDER SHVMS, LLC, d/b/a SANTE VENTURES, : Defendant. :

LEWIS J. LIMAN, United States District Judge: Defendant SHVMS, LLC, d/b/a/ Santé Ventures (““Defendant” or “Santé”) moves for summary judgment dismissing Plaintiff Youngjoo Rhee’s (“Plaintiff’ or “Rhee”) causes of action brought under her Third Amended Complaint (“TAC”), Dkt. No. 42. Dkt. No. 75. In her TAC, Plaintiff brings claims of breach of contract, unjust enrichment, and breach of fiduciary duty. Dkt. No. 42. For the following reasons, the motion is granted in part and denied in part. BACKGROUND The following facts are drawn from the Parties’ Rule 56.1 Statements and the materials submitted in connection with the motion. Dkt. Nos. 77, 79.! Such facts are undisputed unless otherwise indicated, and the Court draws all reasonable inferences in favor of Plaintiff, the non- moving party.

' Plaintiff failed to properly submit a Rule 56.1 Counterstatement. Instead, Plaintiff filed responses to the individual paragraphs in Defendant’s Rule 56.1 Statement in her memorandum of law in opposition to the motion. Plaintiff does not include any additional paragraphs of material facts. For the purposes of this motion, this Court construes those responses as Plaintiff's Rule 56.1 Counterstatement.

Defendant is a private hedge fund focused on managing and developing venture capital funds in the “Biotech, Medtech, and Healthtech fields.” Dkt. No. 77 ¶ 1; Dkt. No. 78-1 ¶ 2. Its business involves raising and then allocating capital to funds. Dkt. No. 78-1 ¶ 2. Once those funds reach adequate capital, they are invested in companies within certain targeted industries. Id. The fund is then closed after a period of time, and Defendant begins the cycle again. Id.

Plaintiff began working for Defendant in 2010 as the Director of Marketing and Investor Relations. Dkt. No. 77 ¶ 2; Dkt. No. 78-1 ¶ 3. The original terms of her employment were set forth in an offer letter, delivered to her via email, on August 18, 2010 (“Employment Agreement”). Dkt. No. 77 ¶ 3; Dkt. No. 78-2. The Employment Agreement provides for Plaintiff to be paid “Annual Base Compensation.” Dkt. No. 78-2 at ECF p. 1. Among its terms, the Employment Agreement also provides for “Incentive Compensation.” Id. One of those incentives is described as a “Cash Bonus” based on the amount of capital raised for Defendant’s funds. That provision states that Plaintiff would be compensated in the following way: Cash Bonus: 1.00% of the total amount of capital directly raised, paid in equal quarterly installments over three years. 100% vested upon closing each LP; adjusted appropriately in the case of a defaulting LP. For example, if you are directly involved in sourcing, qualifying and helping us close $60[ million] in capital in Fund II, then your incentive compensation would be an additional $600,000 paid quarterly over three years, or $50,000 per quarter. Id. The Employment Agreement also awards “Carried Interest” in Defendant’s second fund (“Fund II”) based on the amount of capital Plaintiff raises: Carried Interest: 0.50% of the carried interest in Fund II per $20[ million] of capital directly raised, up to a maximum of 2.00%. For example, if you are directly involved in sourcing, qualifying and helping us close $60[ million] in capital in $200[ million] Fund II that achieves its target of a 3.0x gross return, this would result in pre-tax proceeds to you of approximately $1,750,000. Your carried interest would be 50% vested upon closing each $20[ million] grant threshold, with the balance vesting monthly over six years. Id. The Employment Agreement does not award carried interest for any subsequent funds raised by Defendant. The parties dispute when Defendant concluded that the Cash Bonus payment structure was improper transaction-based compensation under the regulations promulgated by the United States Securities and Exchange Commission (“SEC”) because Plaintiff lacked a broker license. See Dkt. No. 79 ¶ 5; Dkt. No. 78-5 at 28–30.2 The Employment Agreement does not

describe the functions Plaintiff was to perform as Director of Marketing and Investor Relations. Unlike its briefing on the motion to dismiss, Defendant does not claim in its Rule 56.1 Statement or its briefing that the Employment Agreement was subsequently modified by the parties. In her role as Director of Marketing and Investor Relations, Plaintiff contacted potential investors for Defendant’s Fund II between 2010 and 2011. Dkt. No. 77 ¶ 6; Dkt. No. 78-4 at 23– 25. During her employment with Defendant, Plaintiff was not a licensed broker. Dkt. No. 77 ¶ 7. In the fall of 2011, when Santé closed out investments in Fund II, it issued Rhee a $200,000 discretionary bonus that was paid over the following 12 quarters. Dkt. No. 77 ¶ 8; Dkt. No. 78-1 ¶ 5. Rhee had contacted the Pennsylvania Public School Employees’ Retirement Systems

(“PSERS”) as a potential investor in Fund II, but PSERS did not invest. Dkt. No. 77 ¶ 12; Dkt. No. 78-4 at 28–30. The parties dispute Plaintiff’s activities between 2012 and 2017, with Defendant stating only that she “continued to work in the same role” with no additional description of what her activities were or what the precise contents of her prior role was, Dkt. No. 77 ¶ 9; Dkt. No. 78-1 ¶ 6, and Plaintiff stating that “[Defendant] was not actively fundraising from 2012 to 2017,” Dkt. No. 79 ¶ 9; Dkt. No. 79-1 ¶ 9.

2 The portions of Plaintiff’s response to this paragraph in Defendant’s Rule 56.1 Statement arguing that there was not a subsequent modification based on the Employment Agreement’s purported illegality does not controvert the statement that Defendant at some point concluded that the Employment Agreement was illegal. Dkt. No. 79 ¶ 5. Plaintiff eventually focused her efforts on raising capital for a subsequent Fund III. Dkt. No. 77 ¶ 9; Dkt. No. 78-1 ¶ 6. In 2019, Rhee was contacted by Patrick Knapp of PSERS in connection with a potential investment in Fund III. Dkt. No. 77 ¶ 13; Dkt. No. 78-4 at 45; Dkt. No. 78-5 at 17–18. Rhee’s initial involvement with PSERS’s investment in Fund III consisted of qualifying PSERS as an investor. The process of qualification included contacting PSERS and

providing information about Santé, finding the right people within PSERS to receive information about Santé, maintaining contact with PSERS during the process, and introducing Knapp to Kevin Lalande, Santé’s founder, and others within Santé. Dkt. No. 77 ¶ 14; Dkt. No. 78-4 at 45– 46, 72–74. Plaintiff asked “Knapp what his intention was in terms of receiving the information about [Fund] III and what he does within the organizations, what his backgrounds were and the structures,” and described the “process of how—if they were to have an interest with investing with us, what it would look like and timeline will be.” Dkt. No. 78-4 at 46. Those qualifications include the “type of institution, size and other portfolios that have invested in the past, as well as their mandates.” Id. at 74. Plaintiff participated in at least three calls between PSERS and

Lalande and also participated in separate conversations with PSERS without Lalande present. Id. at 46–47. She did not negotiate the terms of PSERS’s participation in Fund III. Id. at 47. Plaintiff also provided support closing the transaction, which consisted of “hav[ing] the right people directed to the right person within Santé” and “aiding with the other meetings up until . . . negotiations or . . . other legal discussions.” Id. at 74. She helped with “continuing the conversations, follow-ups, sending whatever materials they have requested as well as leading . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Leonard
529 F.3d 83 (Second Circuit, 2008)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Train v. Ardshiel Assoc
805 F.2d 391 (Second Circuit, 1986)
Revak v. SEC Realty Corp.
18 F.3d 81 (Second Circuit, 1994)
Laura Holtz v. Rockefeller & Co., Inc.
258 F.3d 62 (Second Circuit, 2001)
Levion v. Societe Generale
503 F. App'x 62 (Second Circuit, 2012)
Holcomb v. Iona College
521 F.3d 130 (Second Circuit, 2008)
WWBITV, INC. v. Village of Rouses Point
589 F.3d 46 (Second Circuit, 2009)
Jaramillo v. Weyerhaeuser Co.
536 F.3d 140 (Second Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Rhee v. Sante Ventures, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rhee-v-sante-ventures-nysd-2023.